Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
The biggest opportunity lies in rapid free cash flow expansion and organic balance sheet deleveraging as multi-year transformation mega-projects conclude.
Annual capital expenditures exceeding $4.5B in FY2026 or credit spreads widening such that computed WACC exceeds 12.34%.
We maintain a Hold rating on Air Products and Chemicals Inc. (APD) with a composite fair value of $251.01 per share against a market price of $273.33 (as of 2026-10-01), representing an implied return of -8.17% and an 8.89% market premium. While management's guided capital expenditure step-down to $3.5 billion in FY2026 from peak FY2025 outlays of $7,022.6 million marks the crest of its megaproject buildout, current valuation fully reflects this operational inflection against elevated leverage of $18,406.2 million and muted international manufacturing demand.456
Air Products' core defensive strength rests on its integrated industrial gas infrastructure, anchored by the Americas segment. In FY2025, the Americas delivered $5,125.9 million in revenue and $1,519.6 million in operating income, generating a segment operating margin of 29.6%, with United States operations contributing $4,692.5 million. These operations are protected by multi-decade on-site pipeline contracts containing minimum take-or-pay volume thresholds and automatic pass-through formulas for natural gas and electricity tariffs. This contractual structure insulates group baseline earnings from commodity price volatility and establishes high customer switching costs along key pipeline networks.7
The central operational catalyst for the business is the turning of its multi-year capital expenditure cycle. Capital spending reached an all-time peak of $7,022.6 million in FY2025, following $6,796.7 million in FY2024, consuming 58.3% of annual revenue and depressing free cash flow to the firm. Management has formally guided FY2026 capital expenditures down to approximately $3.5 billion, marking a 50.2% reduction in capital intensity. As flagship assets such as the Texas clean ammonia and Louisiana Darrow facilities transition toward commercial operation, capital reinvestment rates will normalize from 80% toward a steady-state 25%, inflecting free cash flow back toward historical run-rates.568
Counterbalancing this capital cycle inflection are elevated financial leverage and persistent international manufacturing sluggishness. Total debt expanded to $18,406.2 million at the end of FY2025 against cash of $1,856.0 million and current liabilities of $4,218.6 million. Operating income in FY2025 was -$877.0 million and GAAP net income stood at -$394.5 million, reflecting non-cash impairment charges. Internationally, revenue in China of $1,933.5 million and Europe of $2,984.5 million faces subdued industrial demand, with merchant pricing power constrained outside liquid bulk and overcapacity persisting in Asian industrial markets.4567
The synthesis assigns a 55% weight to multi-stage moat fade ($279.63 midpoint), which captures the durable cash-generation power of long-term on-site contracts at an 8.6548% cost of equity, and a 45% weight to forward earnings ($216.02 midpoint), reflecting post-event consensus FY2027 diluted EPS of $14.44 and an 18.0x terminal multiple. At a market price of $273.33 (as of 2026-10-01), shares trade at an 8.89% premium to fair value with an implied return of -8.17%. Sell-side analyst consensus 12-month price targets average $345.11 ($317.62 present-value equivalent discounted at 8.6548%), reflecting more aggressive margin and multiple expansion than warranted given refinancing requirements and international volume stagnation.124
Management guides FY2026 capital expenditures down to approximately $3.5 billion from peak FY2025 spending of $7,022.6 million. As major clean hydrogen and ammonia projects reach commercial readiness, capital reinvestment normalizes, restoring free cash flow toward historical levels.568
Air Products' core Americas operations generated $5,125.9 million in revenue and $1,519.6 million in operating income in FY2025, delivering a 29.6% . Multi-decade take-or-pay pipeline supply contracts pass through electricity and natural gas feedstocks, insulating baseline cash generation from commodity price .
Hold. At $273.33, Air Products trades at an 8.89% premium to our composite fair value of $251.01 (implied return of -8.17%). While the capital expenditure reduction to $3.5B in FY2026 represents a critical step-down from peak spending of $7,022.6M, elevated debt of $18,406.2M and soft manufacturing volumes in China ($1,933.5M revenue) warrant maintaining existing positions rather than deploying incremental capital.4567
AIR PRODUCTS AND CHEMICALS, INC. designs and manufacture equipment for air separation, hydrocarbon recovery and purification, and liquid helium and liquid hydrogen transport and storage. The Corporate and other segment includes activity related to the sale of cryogenic and gas processing equipment for air separation. The equipment is sold worldwide to customers in a variety of industries, including chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing. This business segment includes its sale of equipment businesses for which equipment is manufactured in Missouri in the United States; Shanghai, China; and Johor, Malaysia. The Gardner Cryogenic business operates at facilities in Pennsylvania and Kansas in the United States.
Its Corporate and other segment also includes the results of its turbo machinery and distribution sale of equipment businesses. Competition for its sale of equipment businesses is based primarily on plant efficiency and technological performance, service, technical know-how, and price, as well as schedule and plant performance guarantees.
Under an integrated stress scenario where execution timing challenges extend megaproject buildout, annual capital spending remains elevated near $4.5B through FY2027 while consolidated operating margins remain suppressed below 18.5% due to fixed cost inflation and flat merchant gas utilization in China and Europe. With $18,406.2M in total debt against $1,856.0M in cash and current liabilities of $4,218.6M, rising refinancing rates would absorb cash generation, slowing balance sheet deleveraging and depressing return on invested capital. This structural capital cycle friction would derate the forward P/E multiple from 19.92x toward 14.4x, compressing intrinsic value toward the lower bound of valuation.
Air Products and Chemicals Inc. operates a durable narrow economic moat built on high customer switching costs and efficient scale along integrated pipeline networks. The foundation of the business resides in the Americas segment, which generated $5,125.9M in revenue and $1,519.6M in operating profit in FY2025, delivering a segment operating margin of 29.6%. United States operations accounted for $4,692.5M or 39.0% of consolidated group revenue. These operations are underpinned by long-term take-or-pay contracts spanning 15 to 20 years, incorporating automatic pass-through formulas for energy feedstocks that shield baseline operating returns from commodity price volatility.
The company's competitive advantage is reinforced by an oligopolistic global market structure shared primarily with Linde and European competitors. However, unlike peer Linde, which achieves an operating margin of 28.12% and net margin of 20.44%, Air Products faces structural limitations in merchant pricing. Management has clarified that because APD lacks a significant packaged gas distribution business in the Americas, its ability to push price increases is largely confined to liquid bulk products, alongside helium pricing headwinds. Furthermore, corporate and other unallocated expenses produced an operating loss of -$367.3M in FY2025, contributing to a consolidated GAAP operating loss of -$877.0M.
The highlighted cell is Fair value when every assumption sits at its base level ($251.01). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $423.5M after modeled reinvestment of $1.7B, with terminal value at 77.0% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to , reinvestment, or resets materially.
A decisive beat driven by accelerating liquid bulk volumes, resilient Americas margins, and capex contained strictly below guided capital moderation targets confirms the capital cycle inflection and warrants an upgraded rating band.
Industry benchmark data establishes an average capex-to-revenue ratio of 4.1% and a capex-to-depreciation ratio of 1.55. In contrast, Air Products underwent an extraordinary multi-year capital deployment phase, with capital expenditures reaching $6,796.7M in FY2024 and cresting at $7,022.6M in FY2025, which represented 58.3% of consolidated revenue and 4.49x annual depreciation of $1,564.2M. Management guidance has formally capped FY2026 capex at approximately $3.5B, marking the definitive crest and downward inflection of the capital cycle.56
A moderate conviction level reflects the tension between Air Products' high-quality core franchise (Americas 29.6% operating margin) and the elevated leverage resulting from peak capital spending ($18,406.2M total debt). With the stock trading at $273.33 as of 2026-10-01 at an 8.89% premium to the house fair value midpoint of $251.01, an existing position should be held but fresh capital allocation kept neutral.47
Risk management centers on capital cycle discipline and balance sheet oversight. Investors should cap total portfolio exposure at 2-3% given elevated corporate debt ($18,406.2M) and macroeconomic exposure to industrial manufacturing cycles in Europe and China. Quarterly earnings releases must be monitored for strict execution against the $3.5B capex ceiling. Any persistent cost overruns on first-of-a-kind clean energy projects or margin compression in the core Americas pipeline business would necessitate reducing position sizing.
Air Products possesses an established Narrow moat supported by long-term take-or-pay pipeline networks in the Americas (29.6% operating margin in FY2025). Existing positions should be maintained as multi-year capex steps down to $3.5B in FY2026, restoring free cash flow. However, adding fresh capital is unwarranted given the 8.89% price premium over intrinsic fair value ($251.01 vs $273.33).457
Near-term cyclical upside is constrained by flat merchant manufacturing volumes in China ($1,933.5M FY2025 ) and subdued industrial activity in Europe ($2,984.5M FY2025 revenue). Cyclical investors should hold existing exposure but withhold incremental buying until industrial production indicators inflect positively.
Maintain existing positions in Air Products and Chemicals Inc. (APD) with a Fair value of $251.01 against current market trading at $273.33 (as of 2026-10-01). While the halving of capital expenditures from $7,022.6M in FY2025 to $3.5B in FY2026 marks a pivotal free cash flow inflection, shares trade at an 8.89% premium to intrinsic value with debt elevated at $18,406.2M.456
Investors should wait for clear quarterly evidence of capex deceleration and initial commercial cash flows from clean hydrogen and ammonia assets before committing fresh capital. Existing holders are supported by the high-margin Americas pipeline network (29.6% in FY2025) and post-event consensus FY2027 of $14.44.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
Operating alongside Linde in a consolidated global oligopoly, Air Products benefits from high distribution density and significant switching costs. Post-event consensus estimates project FY2027 diluted EPS reaching $14.44 on revenue of $13,493.99 million, supported by management guidance of 11% to 12% full-year adjusted EPS growth.15
In the downside scenario, project execution timing delays keep annual capital spending elevated above guided levels, delaying free cash flow inflection. Concurrently, persistent merchant manufacturing overcapacity and energy cost pressures in Europe and China compress merchant gas pricing and volumes. High balance sheet debt ($18,406.2M) amidst higher interest rates elevates interest burdens and curtails discretionary capital returns, depressing consolidated operating margins and compressing valuation multiples toward historical cyclical troughs.
Americas operations face rising fixed cost inflation, distribution dislocations, and maintenance costs with pricing power restricted to liquid bulk, alongside helium pricing headwinds. If consolidated operating margin falls below 18.5% (against the forecast 21.5%), earnings power is significantly impaired.5
APD carries total debt of $18,406.2M against cash of $1,856.0M and current liabilities of $4,218.6M, elevating balance sheet leverage and refinancing vulnerability against near-term debt maturities. A 200 bps widening in credit spreads and refinancing yields increases WACC from 10.3404% above 12.34%.246
Current forward P/E is 19.92x and terminal multiple is authored at 18.0x. Continued negative GAAP earnings (FY2025 net income of -$394.5M) and failure of mega-projects to earn expected returns would derate APD's forward multiple below 14.4x (a 20% contraction).46
The five developments that would weaken our investment case.
Capital expenditures exceeding $4.5B would falsify the capital cycle normalization thesis, indicating megaproject cost inflation or timeline delays that defer free cash flow recovery.
Current:$7,022.6M in FY2025
Alert ifAnnual capex > $4,500M in FY2026
Failure to recover operating margin toward 18.5% (against the forecast 21.5%) indicates persistent merchant pricing limits and maintenance dislocations.
Current:-7.29% GAAP EBIT margin in FY2025
Alert ifConsolidated operating margin < 18.5% over the next 12 months
A drop below 25.0% would signal an erosion in core pipeline take-or-pay pricing power or rising distribution dislocations, damaging the company's highest-margin earnings anchor.
Current:29.6% ($1,519.6M operating income on $5,125.9M revenue in FY2025)
Alert ifAmericas segment operating margin < 25.0% in FY2026-FY2027
A 200 bps widening in credit spreads and refinancing yields on $18,406.2M of total debt elevates capital costs and heightens refinancing vulnerability against current liabilities of $4,218.6M.
Current:10.3404% as of 2026-10-02
Alert ifComputed WACC > 12.34%
Ongoing revenue contraction in China would indicate that industrial overcapacity and flat merchant demand are structural rather than cyclical, capping international expansion.
Current:$1,933.5M in FY2025
Alert ifChina revenue growth <= -5.0% in FY2026-FY2027
Despite these cyclical and corporate overhead frictions, the core network moat remains intact. International segments in Asia ($3,271.0M revenue, $851.1M operating profit, 26.0% margin) and Europe ($2,984.5M revenue, $844.7M operating profit, 28.3% margin) maintain robust baseline profitability. As management curbs transformation capital outlays from the peak $7,022.6M level in FY2025 to the guided $3.5B ceiling in FY2026, economic profits are expected to rebound as new world-scale ammonia and hydrogen assets begin commercial deliveries.
Reported ROIC of 7.13% currently sits below the computed enterprise WACC of 10.3404%. This economic profit deficit is an artifact of peak capital cycle intensity, during which $7,022.6M of FY2025 capital expenditures and $18,406.2M of total debt expanded the invested capital base while megaprojects remained under construction, alongside discrete FY2025 GAAP operating losses of -$877.0M. As capital deployment is guided down to approximately $3.5B in FY2026 and new clean energy assets commission into long-term commercial offtake contracts, ROIC is projected to normalize above the cost of capital.2456
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Solve for the growth rate that makes the model value equal the report-date share price.
In the base scenario, capital expenditure moderates to the guided $3.5B ceiling in FY2026 from $7,022.6M in FY2025, enabling a sharp free cash flow recovery. The Americas segment maintains defensive operating margins near 29.6% ($1,519.6M operating income on $5,125.9M revenue), supported by long-term take-or-pay on-site pipeline contracts. Asia operations stabilize as advanced electronics demand balances flat broad merchant manufacturing. Consolidated FY2027 diluted EPS reaches $14.44 and revenue reaches $13,494.0M, supporting a composite fair value midpoint of $251.01.1567
In the bull scenario, capital expenditures step down rapidly toward maintenance levels below $3.0B following completion of major clean hydrogen and ammonia projects, while commercialized facilities generate immediate high-margin offtake revenue. Americas core pipeline density expands pricing power, and a synchronized industrial manufacturing recovery in China and Europe re-accelerates merchant liquid gas volumes. Consolidated operating margins expand above 23%, net debt rapidly amortizes, and normalized earnings power exceeds consensus FY2027 projections, supporting intrinsic value reaching $304.72.5
Results matching expectations confirm that operations are progressing along the guided capital moderation path, but valuation trading at a premium to Fair value midpoint warrants maintaining the existing rating.
A miss driven by cost inflation, maintenance dislocations in the Americas, or capex overruns indicates persistent capital inefficiency and elevated debt burdens, warranting a rating downgrade.
Reported earnings quality reflects an underlying divergence between GAAP and non-GAAP figures. In FY2025, consolidated GAAP operating income collapsed to -$877.0M and GAAP net income to -$394.5M, driven by unallocated corporate overhead and discrete charges (-$367.3M). In contrast, operating segments delivered $3,225.0M in combined operating profit across Americas ($1,519.6M), Asia ($851.1M), and Europe ($844.7M). Operating cash flow remained robust at $3,248.8M. Management guided full-year non-GAAP EPS of $13.39 to $13.49. High earnings quality is confirmed in underlying divisional cash generation, though GAAP results remain clouded until megaproject construction concludes.4567
Halving capital intensity is the vital catalyst required to unlock positive free cash flow and arrest debt expansion.
Verifies whether long-term take-or-pay contracts continue to protect profitability against fixed-cost inflation and maintenance dislocations.5
Commercial delivery converts capital assets from non-productive cash absorption into recurring high-margin operating cash flow.
Monitors whether broader manufacturing recovery emerges to drive merchant liquid gas volume and pricing realization.
Ensures that operational cash generation is deployed to pay down debt rather than absorbing higher refinancing borrowing costs.
| $12.70B |
| $12.60B |
| $12.10B |
| $12.04B |
| — |
| -1.8% |
| Gross profit | $3.36B | $3.77B | $3.93B | $3.78B | — | +4.0% |
| Operating income | $2.34B | $2.49B | $4.47B | $-877.0M | — | — |
| Net income | $2.26B | $2.30B | $3.83B | $-394.5M | — | — |
| EPS (diluted) | $10.14 | $10.33 | $17.18 | $-1.77 | $9.83 | -0.8% |
| EBITDA | $4.22B | $4.42B | $6.49B | $1.34B | — | -31.8% |
| R&D | $102.9M | $105.6M | $100.2M | $96.3M | — | -2.2% |
| SG&A | $900.6M | $957.0M | $942.4M | $906.1M | — | +0.2% |
Operating cash flow generation remained healthy at $3,248.8M in FY2025, reflecting stable underlying cash collections from long-term on-site contracts. However, free cash flow was heavily negative due to peak capital expenditures of $7,022.6M, contrasting with historical positive free cash flow of $877.7M in FY2021 when capital intensity was lower. With FY2026 capex guided down to $3.5B, free cash flow to the firm is positioned to turn positive ($423.5M projected in FY2026, rising toward $988.3M in FY2027), eliminating the need for external debt financing.4568
Air Products' capital allocation has been defined by an aggressive multi-year megaproject buildout, with capital expenditures reaching $6,796.7M in FY2024 and peaking at $7,022.6M in FY2025. This capital surge was funded largely through debt issuance, pushing total debt to $18,406.2M as of FY2025 against cash of $1,856.0M. Management guidance now caps FY2026 capex at approximately $3.5B, marking a crucial pivot toward capital discipline. CFO Schaeffer indicated that capital allocation will prioritize high-return project completion and dividend continuity ($7.24 per share annual run rate), with discretionary share buybacks scheduled in the waterfall for late 2027 or 2028 conditional on project milestones.
The current gap between reported ROIC (7.13%) and WACC (10.3404%) is an outcome of the peak capital cycle. During FY2024-FY2025, Air Products deployed over $13.8B in capital expenditures, substantially inflating the invested capital base with assets currently under construction that have not yet generated commercial operating income. As capital spending normalizes to $3.5B and facilities like Darrow and Texas clean ammonia enter service, asset turnover and operating earnings will rebound, driving ROIC back above the cost of capital.
Reported ROIC of 7.13% currently sits 3.21 percentage points below the computed enterprise WACC of 10.3404%.
FY2025 capex crested at $7,022.6M and is guided to step down by 50% to $3.5B in FY2026 against operating cash flow of $3,248.8M.
The sharp reduction in capital reinvestment halts multi-year cash burn and turns free cash flow positive, providing immediate support for balance sheet stabilization.
Americas delivered $1,519.6M in operating profit on $5,125.9M in revenue (29.6% margin), while consolidated GAAP operating income was -$877.0M due to discrete corporate charges.
Core franchise profitability remains highly intact; consolidated losses reflect transitory project overhead and impairments rather than structural erosion of business model economics.
Total debt reached $18,406.2M as of FY2025 with cash of $1,856.0M and current liabilities of $4,218.6M under a 5.26% risk-free rate environment.
Financial flexibility is constrained; management must adhere strictly to the $3.5B capex ceiling to avoid credit spread widening and elevated debt service burdens.
| Revenue | $3,161,000,000 |
|---|---|
| Cost of revenue | $2,125,000,000 |
| Gross profit | $1,036,000,000 |
| Operating expenses | $3,133,100,000 |
| Operating income | -$2,097,100,000 |
| Non-operating items and tax | $656,300,000 |
| Net income | -$1,440,800,000 |
| Total assets | $41,059,500,000 |
|---|---|
| Cash | $1,856,000,000 |
| Current assets | $5,825,800,000 |
| Total liabilities | $23,709,700,000 |
| Current liabilities | $4,218,600,000 |
| Shareholders’ equity | $17,349,800,000 |
| Net income | $3,828,200,000 |
|---|---|
| Operating inflow | $5,341,100,000 |
| Depreciation and amortization | $1,451,100,000 |
| Stock-based compensation | $61,800,000 |
| Operating cash flow | $3,646,700,000 |
| Operating outflow | $1,694,400,000 |
| Cash available | $7,898,900,000 |
| Beginning cash | $1,617,000,000 |
| Financing inflow | $2,615,400,000 |
| Exchange-rate effect | $19,800,000 |
| Investing outflow | $4,919,200,000 |
| Ending cash | $2,979,700,000 |
| Investing cash flow | -$4,919,200,000 |
| Financing cash flow | $2,615,400,000 |
Source: SEC EDGAR · Filed 2025-11-20 · SEC EDGAR
| Revenue by operating segment | Revenue | Share | YoY |
|---|---|---|---|
| Americas | $5.1B | 42.6% | 1.7% |
| Asia | $3.3B | 27.2% | 1.4% |
| Europe | $3B | 24.8% | 5.7% |
| Corporate And Other | $520M | 4.3% | -40.8% |
| Middle East And India | $135.9M | 1.1% | 1.1% |
Source: SEC EDGAR · Filed 2025-11-20 · SEC EDGAR
| Revenue by geography | Revenue | Share | YoY |
|---|---|---|---|
| Other Foreign Operations | $5.4B | 45% | 3.4% |
| United States | $4.7B | 39% | -4.5% |
| China | $1.9B | 16.1% | -0.9% |
Point-in-time financial data used in the 2026-10-02 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $8.2B | $2.4B | $3B | $1.6B | $528.2M | $1B | $865.8M | $39.9M | — | $787.9M | — | $2.3B | -$2B | $1.3B | $3.3B | $3.7B | $4B | 17.6% | — | 6.1% | — |
| 2018-09-30 | $8.9B | $3.1B | $1.5B | $2.5B | $973.5M | $1.6B | $970.7M | $38.8M | — | $897.8M | — | -$1.6B | -$1.4B | $3.3B | $2.8B | $3B | $3.8B | 22.0% | — | 6.6% | — |
| 2019-09-30 | $8.9B | $3.5B | $1.8B | $3B | $980.2M | $2B | $1.1B | $41.2M | — | $994M | — | -$2.1B | -$1.4B | $2.8B | $2.2B | $2.4B | $3.3B | 24.0% | — | 5.2% | — |
| 2020-09-30 | $8.9B | $3.7B | $1.9B | $3.3B | $755.7M | $2.5B | $1.2B | $53.5M | — | $1.1B | — | -$3.6B | $3.3B | $2.2B | $5.3B | $6.4B | $8.3B | 25.3% | — | 4.1% | — |
| 2021-09-30 | $10.3B | $4B | $2.1B | $3.3B | $877.7M | $2.5B | $1.3B | $44.5M | — | $1.3B | — | -$2.7B | -$1.4B | $5.3B | $4.5B | $5.8B | $8.2B | 22.1% | — | 4.7% | — |
| 2022-09-30 | $12.7B | $4.2B | $2.3B | $3.2B | $303.7M | $2.9B | $1.3B | $48.4M | — | $1.4B | $384.1M | -$3.9B | -$1B | $4.5B | $2.7B | $3.3B | $8.3B | 18.4% | — | 7.0% | — |
| 2023-09-30 | $12.6B | $4.4B | $2.3B | $3.2B | -$1.4B | $4.6B | $1.4B | $59.9M | — | $1.5B | $3.2B | -$5.9B | $1.6B | $2.7B | $1.6B | $1.9B | $11B | 19.8% | — | 7.6% | — |
| 2024-09-30 | $12.1B | $6.5B | $3.8B | $3.6B | -$3.2B | $6.8B | $1.5B | $61.8M | — | $1.6B | $3.9B | -$4.9B | $2.6B | $1.6B | $3B | $3B | $15B | 36.9% | — | 6.5% | — |
| 2025-09-30 | $12B | $1.3B | -$394.5M | $3.2B | -$3.8B | $7B | $1.6B | $76.4M | — | $1.6B | $3.9B | -$6.6B | $2.2B | $3B | $1.9B | $1.9B | $18.4B | -7.3% | — | — | — |
Air Products and Chemicals Inc. (APD) trades at 19.9x forward earnings against a peer median of 23.8x. Its EV/EBITDA of 17.4x compares with a peer median of 18.5x. The comparison uses 4 peers: Ecolab Inc., The Sherwin-Williams Company, Linde plc and Nucor Corporation, as of 2026-10-02.
In a synchronized industrial upcycle, manufacturing capacity utilization across the US, Europe, and Asia accelerates merchant atmospheric gas consumption, allowing Air Products to capture high incremental margins on liquid bulk distribution. Concurrently, newly commercialized clean energy and hydrogen megaprojects ramp to full offtake capacity, driving group revenue above consensus FY2027 projections of $13,494.0M, expanding operating margins beyond 22%, and rapidly generating cash to amortize corporate debt.
In a prolonged industrial downcycle, persistent manufacturing weakness in Europe and China restricts merchant liquid gas capacity utilization, eliminating pricing power in uncontracted merchant markets. If megaproject completion dates slip due to execution or distribution bottlenecks, capital spending remains elevated, trapping capital in low-returning assets while high balance sheet debt ($18,406.2M) incurs elevated interest costs in a higher-rate macroeconomic environment.
Air Products occupies an advantaged yet differentiated position within the global industrial gas oligopoly. Relative to industry benchmarks of 35.1% gross margin and 12.4% operating margin, APD's operating segments generate superior underlying margins: Americas delivered a 29.6% operating margin ($1,519.6M profit on $5,125.9M revenue), Europe delivered 28.3% ($844.7M profit on $2,984.5M revenue), and Asia delivered 26.0% ($851.1M profit on $3,271.0M revenue). However, primary peer Linde commands a group operating margin of 28.12% and EV/EBITDA of 17.44x, whereas APD incurred a consolidated GAAP operating loss of -$877.0M in FY2025 due to unallocated corporate overhead and project expenses. Furthermore, APD's capital intensity has run far ahead of peers, leaving it with higher leverage but significant first-mover asset exposure to global clean hydrogen and ammonia markets.67
The dividend stream ($7.24 per share) is protected by stable operating cash flow of $3,248.8M in FY2025, but discretionary cash returns through share buybacks remain deferred until late 2027 or 2028 while total debt of $18,406.2M is addressed.45
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
| The Sherwin-Williams Company |
| $77.9B |
| 23.6x |
| 3.2x |
| 19.6x |
| 65.1% |
| 18.1% |
| LIN | Linde plc | $216.4B | 24.0x | 6.1x | 17.4x | 18.4% | 28.1% |
| NUE | Nucor Corporation | $53.5B | 11.9x | 1.5x | 10.4x | 14.5% | 15.7% |
